NCT02016846Unknown3 期
Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- Glucose levels 2 hours after 75 gr OGTT
研究概览
简要总结
Glucocorticoids therapy exposes the patient to an increased risk for diabetes morbidity. However, there is no proven preventive therapy. GLP-1-RA has shown to improve glucose metabolism in healthy volunteers treated with glucocorticoids. We assume that GLP-1-RA will improve glucose metabolism in patients with high risk for diabetes morbidity, treated with glucocorticoids.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
Intervention
Active Comparator
Liraglutide, tapered from 0.6 mg/day to 1.8 mg/day.
干预措施: Liraglutide (Drug)
结局指标
主要结局
Glucose levels 2 hours after 75 gr OGTT
时间窗: 6 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized PatientsDiabetes MellitusHyperglycemiaNCT01810952Baylor College of Medicine37
Unknown
早期 1 期
Effect of Glucocorticoid on Exogenous Insulin Antibody SyndromeDiabetes Mellitus, Type 2NCT04357392chenfengling20
招募中
不适用
Diabetes Screening in Patients on Long-Term Glucocorticoid TherapyGlucocorticosteroidDiabetesNCT04258293Centre Hospitalier Universitaire Dijon75
Unknown
不适用
Liraglutide and Insulin Therapy in Patients With Type 2 DiabetesType 2 Diabetes MellitusNCT01392898Radboud University Medical Center50
Unknown
不适用
Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor GeneRheumatoid ArthritisNCT01411046Rigshospitalet, Denmark106